Early recognition and management of acute kidney injury are critical to optimize outcomes among patients with advanced liver disease.
Patients with viral hepatitis-related cirrhosis are known to be at increased risk of hepatocellular carcinoma and cholangiocarcinoma, and early detection greatly improves outcomes. Yet far too few patients are not being screened, said Amit Singal, MD, from UT-Southwestern Medical Center, at the…
The director of the National Institute on Allergies and Infectious Diseases, Dr Anthony Fauci, led off a panel that reviewed the impact of COVID-19 on liver function and on patients with liver disease at the American Association for the Study of Liver Diseases meeting.
Gastroenterologists and hepatologists must carefully assess and interpret studies of iron deposition to guide treatment of patients with both genetic and secondary hemochromatosis, Vinday Sundaram, MD, explained at the American Association for the Study of Liver Diseases.
Big decreases in the cost of gene sequencing is making the delivery of precision care to patients with liver disease increasingly feasible, says Scott L. Friedman, MD, at the virtual 2020 Liver Meeting.
An oral presentation at the 2020 ACG Clinical Meeting and Postgraduate Course revealed results from a pooled analysis to determine the outcomes and safety of endoscopic submucosal dissection and endoscopic mucosal resection in therapy for early neoplasia related to Barrett esophagus.
An award-winning poster from the American College of Gastroenterology 2020 clinical meeting examined the outcomes of children who have ileal-pouch anal-anastomosis surgery for treatment of ulcerative colitis.